The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLimitless Earth Regulatory News (LME)

Share Price Information for Limitless Earth (LME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.25
Bid: 2.00
Ask: 2.50
Change: 0.00 (0.00%)
Spread: 0.50 (25.00%)
Open: 2.25
High: 2.25
Low: 2.25
Prev. Close: 2.25
LME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-yearly Report

30 Oct 2015 07:00

LIMITLESS EARTH PLC - Half-yearly Report

LIMITLESS EARTH PLC - Half-yearly Report

PR Newswire

London, October 29

30 October 2015

LIMITLESS EARTH PLC

("Limitless" or the "Company")

UNAUDITED HALF-YEARLY RESULTS FOR THE SIX MONTHS ENDED 31 JULY 2015

The Company is pleased to announce its half-yearly result for the six months to 31 July 2015.

CHIEF EXECUTIVE’S STATEMENT

Limitless is a proactive investing company that focuses on making investments in and assisting companies that show the potential to generate returns through capital appreciation. It is the view of directors to invest in small companies where there are clear routes to value appreciation and the companies are operating in sectors with long term growth prospects that are driven by demographic change. Examples of such sectors include cleantech, life sciences and technology.

The Board is focused on making sure it makes the right investment in the right sector at the right time. It has looked carefully at more than twenty investment opportunities and has, following the period end, made its first investment. During the second half of the financial year, the Board expects to make further investments and it continues to review a number of investment opportunities.

During the reporting period, Mr Guido Contesso was appointed Chief Executive Officer, Mr Dominic White (former CEO) was appointed Non-executive Director and Mr Luca Serri stepped down from the Board. The Company also announced that 3,924,000 warrants, awarded at the time of the Company’s admission to AIM, were cancelled.

The Board understands that cost control is important at all times and particularly pre-investment. On behalf of the shareholders, the directors carefully keep operating costs to a minimum to preserve shareholder value.

For the period, Limitless made a net loss on operations of £77,734 and the unaudited balance sheet reflects the cash and cash equivalents at the reporting date of £2,668,320.

Post reporting period

On 8 October 2015, the company invested US$500,000, by way of convertible preference stock, in Chronix Biomedical Inc. ("Chronix"), a private molecular diagnostics company which is developing blood tests that can be used for applications including cancer detection and organ transplantation.

For further information, please contact:

Limitless Earth plc http://www.limitlessearthplc.com/

Guido Contesso - CEO +44 7972 000 093

Cairn Financial Advisers LLP +44 20 7148 7900

Nominated Adviser http://www.cairnfin.com/

Jo Turner/Tony Rawlinson

Peterhouse Corporate Finance Limited +44 20 7469 0930

Joint Broker http://www.pcorpfin.com/

Peter Greensmith

About LIMITLESS EARTH PLC

Limitless Earth plc is a proactive investment company that focuses on making investments in and assisting companies which exhibit the potential to generate returns through capital appreciation. Limitless invests in small companies where there are clear catalysts for value appreciation and the companies are operating in sectors exhibiting long term growth linked to demographic change. Examples of such sectors include Cleantech, Life Sciences and Technology.

UNAUDITED INCOME STATEMENT ANDSTATEMENT OF COMPREHENSIVE INCOME
6 MONTHS ENDED 31 JULY 2015
NotesUnauditedUnauditedAudited
31/07/1531/07/1431/01/15
Continuing operations£ ££
Administration expenses(87,230)(175,806)(305,914)
Operating loss(87,230)(175,806)(305,914)
Finance Income9,496-6,243
Loss before taxation(77,734)(175,806)(299,671)
Taxation---
Loss for the period(77,734)(175,806)(299,671)
Total Comprehensive loss for the period(77,734)(175,806)(299,671)
Loss attributable to:
Equity Holders(77,734)(175,806)(299,671)
Earnings per share:
Basic loss per share3(0.12p)(0.68p)(0.69p)

 

UNAUDITED STATEMENT OF FINANCIAL POSITION
AS AT 31 JULY 2015
UnauditedUnauditedAudited
31/07/1531/07/1431/01/15
£££
Current assets
Trade and other receivables-23,000-
Cash2,668,3202,841,9542,731,554
2,668,3202,864,9542,731,554
Total Assets2,668,3202,864,9542,731,554
Current Liabilities
Trade and other payables(27,000)(22,035)(12,500)
Net Assets2,641,3202,842,9192,719,054
Equity
Share Capital654,000654,000654,000
Share Premium Account2,322,4402,322,4402,322,440
Share Warrant Reserve42,28542,28542,285
Retained Earnings(377,405)(175,806)(299,671)
Total Equity2,641,3202,842,9192,719,054

UNAUDITED CASH FLOW STATEMENT FOR THE 6 MONTHS ENDED 31 JULY 2015
UnauditedUnauditedAudited
31/07/1531/07/1431/01/15
£££
Cash flows from operating activities
Operating loss(87,230)(175,806)(305,914)
Operating cash flows before movement in working capital (87,230)(175,806)(305,914)
(Increase)/decrease in receivables-(23,000)-
Increase in payables14,50022,03512,500
Cash expended by operations(72,730)(176,771)(293,414)
Cash Flows from Investing Activities
Finance income received net9,496-6,243
Net Cash Used in Investing activities9,496-6,243
Cash flows from financing activities
Proceeds from issue of ordinary shares (net of expenses)-3,018,7253,018,725
Net cash inflow from Financing activities-3,018,7253,018,725
Net increase in cash(63,234)2,841,9542,731,554
Cash at the beginning of period2,731,554--
Cash at the end of the period2,668,3202,841,9542,731,554

UNAUDITED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
FOR THE 6 MONTHS ENDED 31 JULY 2015
Share capitalShare premiumShare warrant reserveRetained earningsTotal
£££££
Changes in Equity for the period ended 31 January 2015
Comprehensive income
Loss for the period and total comprehensive loss--(299,671)(299,671)
Transactions with owners
Proceeds from share issue (net of expenses)654,0002,322,44042,285-3,018,725
Total contributions by the owners654,0002,322,44042,285-3,018,725
At 31 January 2015654,0002,322,44042,285(299,671)2,719,054
Comprehensive income:
Loss for the period and total comprehensive loss---(77,733)(77,733)
At 31 January 2015654,0002,322,44042,285(377,404)2,641,321

 

NOTES TO THE FINANCIAL STATEMENTS

1. General information

Limitless Earth plc is a company incorporated and domiciled in England and Wales. The Company’s ordinary shares are traded on AIM of the London Stock Exchange. The address of the registered office is 30 Percy Street, London W1T 2DB.

The principal activity of the Company is that of an investment company pursuing a strategy that focuses on making investments in and assisting companies which exhibit the potential to generate returns of many multiples through capital appreciation. Typically, Limitless invests in small companies where there are clear catalysts for value appreciation and the companies are operating in sectors exhibiting long term growth linked to demographic change.

2. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the period covered by these financial statements.

Basis of preparation

The interim financial information set out above does not constitute statutory accounts within the meaning of the Companies Act 2006. It has been prepared on a going concern basis in accordance with the recognition and measurement criteria of International Financial Reporting Standards (IFRS) as adopted by the European Union.

The financial statements have been prepared under the historical cost convention.

The interim financial information for the six months ended 31 July 2015 has not been reviewed or audited. The interim financial report has been approved by the Board on 26 October 2015.

3. Loss per share

The basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted earnings per share is computed using the same weighted average number of shares during the period adjusted for the dilutive effect of share warrants and convertible loans outstanding during the period.

 UnauditedUnauditedAudited
31/07/1531/07/1431/01/15
Loss from continuing operations attributable to equity holders of the company(77,734)(175,806)(299,671)
Weighted average number of ordinary shares in issue65,400,00026,024,00043,440,000
PencePencePence
Basic and fully diluted loss per share from continuing operations(0.12)(0.68)(0.69)

IAS 33 requires presentation of diluted earnings per share when a company could be called upon to issue shares that would decrease earnings per share or increase net loss per share. For a loss making company with outstanding share options and warrants, net loss per share would only be increased by the exercise of out-of-the money options and warrants. Since it seems inappropriate that option holders would act irrationally, no adjustment has been made to diluted earnings per share for out-of-the money options and warrants in the comparatives. There are no other diluting share issues.

4. Copy of the half-yearly report

A copy of the half-yearly report is available at the Company´s web site at http://www.limilessearthplc.com/.

12
Date   Source Headline
13th Dec 20232:10 pmPRNResult of AGM
22nd Nov 20231:40 pmPRNNotice of AGM
30th Oct 20231:00 pmPRNHalf-year Report
28th Jul 20237:00 amPRNFinal Results for the year to 31 January 2023
27th Jul 20232:31 pmPRNSubscription and Issue of Equity
7th Feb 20227:00 amPRNHolding(s) in Company
2nd Dec 202111:42 amPRNResult of AGM
29th Oct 20217:00 amPRNHalf-year Report
26th Oct 20212:05 pmRNSSecond Price Monitoring Extn
26th Oct 20212:00 pmRNSPrice Monitoring Extension
26th Oct 20211:42 pmPRNStatement re Share Price Movement
26th Oct 202110:38 amPRNNotice of AGM
30th Jul 20211:51 pmPRNFinal Results
14th Apr 20215:37 pmPRNHolding(s) in Company
19th Mar 20217:00 amPRNChronix Biomedical Investment Update
19th Jan 20217:00 amPRNSaxa Gres Investment Update
30th Oct 20207:00 amPRNHalf-year Report
31st Jul 20207:00 amPRNFinal Results
7th Nov 20198:39 amPRNChange of Registered Office
30th Oct 20191:45 pmPRNHalf-year Report
24th Sep 201912:24 pmPRNResult of AGM
20th Sep 20199:43 amPRNFurther Investment Chronix Biomedical Inc
31st Jul 20197:00 amPRNFinal Results
29th Jan 20192:05 pmRNSSecond Price Monitoring Extn
29th Jan 20192:00 pmRNSPrice Monitoring Extension
25th Jan 20199:00 amRNSPrice Monitoring Extension
30th Oct 20187:00 amPRNHalf-year Report
31st Jul 20187:00 amPRNFinal Results
9th May 20187:00 amPRNUpdate on Investment in Saxa Gres S.p.A
12th Jan 20183:09 pmPRNDirector's Dealings
16th Nov 20176:59 amPRNFurther Investment Saxa Gres
31st Oct 20177:00 amPRNHalf-year Report
12th Sep 201712:30 pmPRNResult of AGM
7th Aug 20177:12 amPRNDirector/PDMR Shareholding
31st Jul 20177:00 amPRNFinal Result and Notice of AGM
5th Jul 20179:05 amRNSSecond Price Monitoring Extn
5th Jul 20179:00 amRNSPrice Monitoring Extension
26th Jun 20177:00 amPRNDirectorate Change
5th Apr 20177:00 amPRNConversion of Investment in V-Nova
21st Mar 20177:00 amPRNFurther Investment Saxa Gres S.p.A
31st Oct 20167:00 amPRNHalf-year Report
5th Sep 201612:34 pmPRNResult of AGM
29th Jul 20167:00 amPRNFinal Results
3rd May 20167:00 amPRNInvestment in Nano Technology
23rd Dec 20152:05 pmPRNInvestment in Industrial Material Recycling
18th Dec 20154:03 pmPRNInvestment in Communication Technology Sector
12th Nov 20159:48 amPRNDirector's Dealing
6th Nov 20151:57 pmPRNDirectorate Change
30th Oct 20157:00 amPRNHalf-yearly Report
8th Oct 20157:00 amPRNInvestment in Medical Diagnostics
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.